Although developed by the RCVS and VSC BAME Student Support Working Group ostensibly for use by Universities, EMS placement host practices and other educational establishments, it is recommended that all veterinary practices review the guidance.
The Guidance on Religious Clothing and Beliefs covers issues such as: balancing accommodations for religious dress with clinical considerations, and making accommodations for religious observance in academic timetabling and exams.
Gurpreet Gill, RCVS Leadership and Inclusion Manager said: “This document is about recognising that personal religious beliefs should be respected and accommodated as far as possible, while also not compromising professional responsibilities such as infection control, effective communication and the health and safety of individuals and their colleagues.
"Most importantly, it is about creating a welcoming and inclusive environment and ensuring that all students are able to express their religious identity whilst participating in educational and workplace settings.
“Although the guidance is not exhaustive, we would highly recommend that, where relevant, educators, practices and other veterinary workplaces review, adopt and adapt this guidance for their own settings to ensure that all members of the professions are welcomed and included.”
The Guidance on Religious Clothing is available to download from: https://www.rcvs.org.uk/news-and-views/publications/guidance-on-religious-clothing-and-beliefs/
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
The programme is the first in a new series of ‘Accelerated’ courses from the company, designed to support those starting out on their postgraduate learning journey or experienced vets who want to refresh their knowledge in a specific subject.
The Accelerated Emergency and Critical Care programme comprises 15 modules covering pathophysiology, diagnosis, management and current treatments.
The modules are delivered on a weekly basis and delegates can study at their own pace. Delegates can also access all the modules for a 12-month period so they can revisit the contents as necessary.
In addition to the modules, delegates have access to a discussion forum and four live sessions with Specialists for clinical case discussions.
At the end of the course, delegates can take a Foundation Certificate from the International School of Veterinary Postgraduate Studies (ISVPS).
The programme was developed by Specialist veterinarians, both Fellows and Members of the Australian and New Zealand College of Veterinary Scientists in Emergency and Critical Care, from Improve International’s Australian Partner, the Animal Emergency Service.
David Babington MRCVS, Business Development Director at Improve International, said: “The growing interest we are seeing from veterinarians around the world in updating their knowledge as we prepare to emerge into the post-COVID world, was the catalyst for the creation of our new Accelerated online course range.
"The Accelerated Emergency and Critical Care Programme is ideal for veterinarians at all stages of their career. It is an example of the ways we are delivering on our strategy of significantly expanding our e-learning portfolio and harnessing technologies, including video teaching and virtual/augmented reality, to offer a more engaging, affordable, accessible and rich learning experience to veterinary professionals around the world."
The VetDebt Recovery Compass tool provides a way for practices to understand how outstanding payments affect their cash flow and practice value, and what steps to take next.
Mike Brooks, Chairman at DSL UK (pictured), said: “The VetDebt Recovery Compass offers a quick and easy way to see the true financial impact of unpaid debt.
"By making this information free and accessible to everyone, we hope to empower veterinary teams to take control of their finances.
DSL says that the new tool, which is available at www.dsluk.net, allows practices to see both the immediate recovery potential and the long-term value impact of their debts in less than 30 seconds.
The calculator also provides a species-specific breakdown, helping to identify where debt issues may be most significant and where to target first.
Mike has also appeared on the Federation of Independent Veterinary Practices (FIVP) Practice Matters Podcast, discussing how practices can better manage the topic of debt: https://fivp.org.uk/ep023-fivp-practice-matters-at-spvs-the-farm-vet-journey-practice-debt.
Noelle Lowry, a marathon-running vet from Lichfield has raised almost £2,500 for the RCVS Trust in the London Marathon.
Noelle beat her fundraising target of £1,500, to raise money for the Trust to use in its work to support veterinary education and research, and in providing library and information services.
She finished 4,594 out of the 11,037 women runners in the London Marathon, taking 4 hours and 36 minutes to run the 26.2 mile long course - and beating her time last year in the New York marathon.
Noelle said: "A lot of people chipped in at the last minute - my mum has been organising people back home in Ballymena and my friends and colleagues have all put their hands in their pockets - so a huge thank you to all of them.
"I'm a great fan of the RCVS Trust. It's not one of the big charity brands but the grant funding for veterinary research can really make a difference to animals - and we can all use the library and online resources - so I wanted to give it some help."
Click here for more about the work of the RCVS Trust
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Those veterinary surgeons being audited are being asked to share their records for 2013 to 2015 by either allowing the College to access their online Professional Development Record or by sending the RCVS a copy of their CPD record cards. The deadline for sharing records is Friday 14 October 2016.
The audit is focused on six groups:
If any of the veterinary surgeons who have been audited are found to be non-compliant (ie. less than 105 hours of CPD over a rolling three-year period), they will be asked to explain why and send a plan stating how they will make up the hours in order to become compliant.
The College says it is also keen to remind veterinary surgeons that CPD encompasses a wide range of recorded activities, which can be clinical or non-clinical, including private reading/study, webinars, mentoring, clinical audit and discussion groups as well as attending seminars and workshops.
More information about what counts as CPD can be found at www.rcvs.org.uk/cpd
Those with any questions about the auditing process or what constitutes CPD can contact Jenny Soreskog-Turp, Education Officer at the College, on cpd@rcvs.org.uk
Ed's note: Don't forget to claim your VetSurgeon.org CPD certificate detailing time you've recorded reading content and taking part in qualifying discussions on the site. Click 'My Account' and then the 'CPD' tab to view your records and create your certificate.
Intraperitoneal and incisional analgesia in small animals: simple, cost-effective techniques1, considers the findings and limitations of recent studies and makes recommendations on the use of IP and incisional analgesia in companion animals.
Paulo Steagall, lead author of the paper said: "Based on current evidence and a consensus of the WSAVA-GPC members, it is recommended that IP and incisional analgesia should be used for abdominal surgery such as intestinal foreign body removal, splenectomy, etc. These techniques can be particularly useful in high-volume sterilisation programmes due to their safety and cost effectiveness. They should never be administered as stand-alone analgesic techniques, but rather should be used in addition, as part of a multimodal analgesic plan with opioids and nonsteroidal anti-inflammatory drugs (NSAIDs)."
The review says that current literature on IP and incisional analgesia has several limitations including the use of different doses, drugs and volumes of local anaesthetic. Furthermore, acute pain assessment was performed using a number of different pain scoring systems with variable validity, by a number of different people which may introduce bias. Further studies are therefore warranted to continue to investigate the use of IP and incisional analgesia in a number of clinical scenarios.
Nicholas Jeffery, editor of JSAP said: "Local anaesthetics are inexpensive and not limited by geographic availability; this review supports their use to manage perioperative pain as part of a multimodal management approach."
The full article can be found in the January issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13084
For further information relating the use of local anaesthesia and the management of perioperative pain, the BSAVA is advising veterinary surgeons to consult a text such as the BSAVA Guide to Pain Management in Small Animal Practice.
Reference
Owners are being asked to provide a photo or video and a brief description that capture what it is like to live with and care for an older dog.
Dr Carri Westgarth, a senior lecturer in human-animal interaction at the University of Liverpool, has been awarded a citizen science grant from PetSavers to run the project. She plans to use the information gathered to help develop a ‘Canine Ageing and Wellbeing’ tool for use in veterinary practice.
Carri said: “Dogs are living up to twice as long as they did 40 years ago and there are implications for senior dogs’ healthcare and wellbeing.
"As life expectancy increases, so does the amount of time the dog may spend in poor health. It may be difficult for us to distinguish between the signs of serious age-related diseases and normal age-related changes in our dogs."
PetSavers says the data will contribute to our investigations of owner expectations, experiences and attitudes to ageing in dogs, including preventative care and general understanding of normal and abnormal changes during ageing.
Carri added: "Improving discussions between owners and veterinary professionals about senior dog care will help to increase owner understanding and involvement in care decisions for their pet. The resulting early detection of health problems should bring significant improvement to the quality of life of senior pets and the dog-owner relationship.
"Any adult UK residents who (currently or recently) live with an aged dog/s of any breed/s or health status are encouraged to participate by choosing an image or short video and telling us about it."
The research team will then analyse the submitted text and media for common themes. They may also use anonymised selected quotes to illustrate important findings in research publications such as scientific papers or conference presentations.
If you know any owners who might like to participate, do share this link with them: https://bit.ly/PetSaversOAPsPhoto
For more information, visit: https://www.petsavers.org.uk/our-research/oldagepets
Data collection will close on Friday 10th July 2020.
The course has been put together by the charity's Investigations Team with the help of Mark Naguib BVMS(Hons) CertAVP(ZooMed) MRCVS.
The course has been designed to help you identify animals which have been targeted by illegal shooting, trapping and poisoning, and how to make sure valuable evidence is preserved for any investigation by the police.
The course includes:
The course is open to anyone in veterinary practice, and is worth 2 hours CPD: https://www.rspb.org.uk/rspb-vet-cpd
The practice is now accepting dental referrals, including for dental, oral and maxillofacial surgery.
Hannah said: “I am proud to join the Fitzpatrick Referrals team to extend their referral offering to include this very important aspect of small animal veterinary treatment.
"Working alongside a world-class team with state-of-the-art facilities is a fantastic opportunity.”
https://www.fitzpatrickreferrals.co.uk/services/dentistry/
Boehringer Ingelheim Vetmedica has launched new, more palatable Metacam Chewable Tablets.
According to the company, the tablets are proven to be taken by 90% of dogs voluntarily1 and 80% will even take them from the floor1 which aids compliance. Available in pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range.
Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, said: "The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising 'beefed up' meaty flavour."
For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959.
Captains Nicola Housby-Skeggs and Claire Budge, the first two members of the Royal Army Veterinary Corps (RAVC) to achieve the RCVS Certificate in Advanced Veterinary Practice (CertAVP), have been presented with their certificates at Belgravia House.
The two Captains were visiting the RCVS as part of a 'Meet the RCVS Day' organised for a group of Officers from the RAVC. The Captains were presented with their Certificates by Vice-President Peter Jinman.
Capt Nicola Housby-Skeggs had completed a mixture of small animal and equine modules in order to achieve her Certificate, and was positive about the modular approach. She said: "It's reassuring to know you can have a break if you need to. The compulsory module on professional key skills was also more useful than I had anticipated, as it focused on aspects that you don't really have time for at vet school, such as management, and health and safety."
Meanwhile, Captain Claire Budge appreciated the fact that many of her modules could be completed via distance learning. She said: "It was great that I could continue with my studies even when serving in Afghanistan. My only regret is that when I started the Certificate back in 2008, there wasn't the range of modules available that there is now. For example, I would like to have done one of the new Animal Welfare, Ethics and Law modules. However, there is no reason why I can't just take this as continuing professional development - that's the benefit of the modular approach."
More information about the CertAVP can be found at www.rcvs.org.uk/modcerts.
'Meet the RCVS Days' give members of the veterinary team the opportunity to visit the College and find out what goes on behind the scenes. If you would like to join a future event, please let Fiona Harcourt know, on f.harcourt@rcvs.org.uk. Reasonable travel expenses are paid.
Pfizer Animal Genetics is expanding its presence in the UK with the appointment of a dedicated team.
The company says it will use state-of-the-art genetic technology to improve the health, welfare and productivity of animals, and that the move comes at an exciting time for genetic research, as complete sequencing of the bovine genome has resulted in explosive growth of the possibilities.
As well as being able to provide tests addressing parentage (SireTRACE) and traceability (SureTRAK), Pfizer Animal Genetics can also help farmers identify the genetic potential that each animal has to produce tender, well marbled meat and to perform at optimal feed conversion efficiency (GeneSTAR) - vital management information that can improve profitability and enable effective decision making in long term breeding plans.
The company promises there is more to come, with exponential growth in the identification of genetic markers, which will allow the imminent introduction of new tests set to provide much more detailed predictive information about individual animals - all available virtually from birth onwards.
Richard Chew (above right) is Customer Service Manager and the first port of call for anyone with questions about pricing & submission forms, samples and reports. Richard grew up in rural Lancashire and went on to study at the University of Bristol. Since graduation his career has taken him through a variety of scientific and customer facing roles. He has worked for Pfizer Animal Health for six years in the clinical development of vaccines and pharmaceuticals for livestock and is looking forward to the new challenges of the genetics business. Richard is based in Pfizer's Surrey office and can be reached on 08345 3037398 or PfizerAnimalGenetics-EU@pfizer.com.
Mike Marron and Peter Quigley are Dairy Sales Manager and Beef and Sheep Sales Manager respectively and will be the contact points for breed associations, organisations and individuals who want to discuss how genetic assessment and identification can help assure the quality of a breed or herd. Mike has an honours degree in biological and biochemical science and a decade of experience in the animal health industry, with special interests in fertility and calf management. Peter also comes from the animal health industry and is looking forward to continuing the company's work with the Aberdeen Angus Society as well as developing programmes for other beef breed societies.
Mike or Peter will be in attendance at various agricultural shows across the UK including Agrilive, the South West Dairy Show, Surecalf, Agriscot, Thainstone Christmas Classic, the Welsh Winter Fair, The Great Yorkshire Show and the Northern Ireland Winter Fair, where they will be explaining how genetic testing can make a contribution towards improving the brand value of a breed and shortening the time frame to allow better management decisions to be made.
Dr Gary Evans is Technical Services Manager and will be providing detailed advice on how to improve pedigree herd books, the interpretation of results of genetic testing and detection of certain genetic diseases. Gary is a geneticist with fourteen years experience in the application of genomics to livestock and joins Pfizer Animal Genetics from PIC/Genus.
The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
John Alborough presented the awards at the event. Liz Rawlings from Dechra said: "It was certainly a whirlwind at this year’s LVS and we are delighted to have scooped such a prestigious award." Zoe Appleyard-Ley, Co-Founder and Managing Director at Rockster Superfood for Dogs said: "We were so excited by the response Rockster had at the London Vet Show, and thrilled to have been given the award by VetSurgeon.org."
The researchers say that the findings pave the way to generating new and important information about the development chronic kidney disease (CKD) and hypertension (HTN) in cats.
The RVC says that about 30% of cats aged 10 years or older have CKD, which equates to approximately 600,000 in the UK.
Of these, about 40% will also have hypertension.
The research team was led by principal investigator at the RVC, Dr Rosanne Jepson, alongside joint first author from Queen Mary University of London, Dr Helen Warren, and Professor Patricia Munroe.
The team examined the archives of 1,022 domestic cats seen at both the RVC’s Beaumont Sainsbury Animal Hospital and Bow PDSA Pet Hospital since 1992, looking for genetic associations with CKD and HTN using a genome-wide association study (GWAS) approach.
The GWAS approach used a special feline array to characterise over 63,000 genetic differences across the feline genome.
The team examined the influence of different genes on disease traits which may point to new ways of treatment as the pathways and proteins controlled by these genes can indicate novel mechanisms for disease development.
Researchers say that this study method has historically been used for rarer and breed-specific conditions where single genetic mutations might be occurring.
However, the findings show it could now be used to generate new information about common and complex diseases which are likely to be the result of genetic, lifestyle and environmental risks.
Rosanne Jepson, Principal Author of the paper and Associate Professor in Small Animal Internal Medicine at the RVC, said: “This was an exciting opportunity to explore potential genetic influences on the development of chronic kidney disease and systemic hypertension in cats, collaborating with key opinion leaders who work and have published extensively in this field in human medicine.
“These conditions are complex - meaning that there are many factors relating to genetics, lifestyle and environment that cumulatively determine whether an individual may develop either CKD or hypertension in their lifetime.
“This study has shown us, as proof of concept, that large scale genomic studies will be important for understanding the pathogenesis of such complex disease conditions and may help to identify novel pathways as targets for diagnosis and management in the future.”
Vets Now, the Out Of Hours emergency vets has announced the launch of Winchester's first dedicated 24/7 pet ambulance service.
Specifically designed for the comfortable and secure transport of all small animals, the new state-of-the-art ambulance is fully kitted out with the latest in emergency equipment.
After completing a course of rigorous training, the fully trained ‘Petamedics' (the animal equivalent of Paramedics), took to the streets of Winchester earlier in the month.
Gareth Roscoe, Vets Now Ambulance Service Team Leader said: "This service will make a real difference to animals in a distressed or critical situation. We've responded to a variety of cases over the past few weeks; one of the most recent ones being a nine week old puppy who was receiving emergency treatment at the Vets Now clinic in Winchester after his owner accidentally fell on him. Charlie was brought to the clinic collapsed and unresponsive with signs of head trauma. The vets set up an intensive treatment plan for him and by the morning, he was almost back to normal and we took him back to his daytime vet.
"The ambulance service provides owners in the Winchester area with the safest and fastest method of transporting their pets to get medical treatment twenty-four hours a day, seven days a week. What's more, the service is also available to owners who have routine transportation problems; so whether owners and their pets are visiting their clinic for a veterinary appointment, attending a referral centre or even going to the groomers, the Vets Now Ambulance offers them a reliable solution to all their pet transportation needs."
The ambulance is a significant new addition to the already established Vets Now Emergency Clinic which is based at the Mildmay Veterinary Centre, Easton Lane in Winchester. Caroline Hirst, Senior Veterinary Surgeon at the emergency clinic commented; "The dedicated 24 hour ambulance has already been called out to help several of our clients ahead of its official media launch on 25 September. As an emergency clinic, we often admit patients overnight, and a real plus of having the ambulance is that we can ensure that pets can be returned to their regular vet or back to their owner in the morning safely and with the minimum of fuss. From experience, Vets Now knows that there are regular occasions when owners are afraid to move their pet if it is unwell or has been involved in an accident. We hope that being able to offer the ambulance service will be of great benefit not only to pets but also to owners, giving them peace of mind that their pet is being cared for and transported in a safe environment until it receives the necessary veterinary treatment at the clinic."
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
The three presentations, which are between 30 minutes and an hour in length, are aimed at vets but may also be of interest to veterinary nurses. They cover: ‘Topical therapy in canine atopic dermatitis’ and ‘Antimicrobial resistance’ presented by Dr Tim Nuttall and ‘Emotional considerations in dealing with dermatology cases’ by Dr Sarah Heath.
The presentations will be available for download from 7th June 2021, and viewers will be able to enter into a prize draw to win a £50 Love2Shop voucher and a free Cytology Manual.
To pre-register, visit: https://www.thewebinarvet.com/pages/ceva-dermatology-tea-time-top-ups-bite-size-cpd-sessions/
If you're attending BEVA this September you can win a place on the CEVA-sponsored Equine Ski-PD break in January 2010, combining a couple of days of first class Continued Professional Development (CPD) with some excellent skiing in the Italian Alps.
The course runs from 13-17 January 2009 and the CPD will be spread over five sessions, equating to two-and-a-half days. Equine vets Jane Boswell, Henry Tremaine, Professor Bruce McGorum, Professor Peter Clegg and Dr Tim Brazil will cover the topics of tendonitis, wound management, ophthalmology, internal medicine and joint disease.
Skiing will be at Courmayeur, a traditional Alpine village on the Italian side of Mont Blanc, where all levels of ability, from beginners to experienced off-piste skiers, can be catered for.
To win your place, which includes flights and four nights b&b accommodation, simply visit the CEVA stand at BEVA and answer a questionnaire on Tildren®, CEVA's bisphosphonate-based treatment for equine bone disease, based on information provided via a short film loop that will be running on the stand.
For further information on equine Ski-PD contact the organisers: ben.mayes@equinevetpractice.co.uk or henry.tremaine@bristol.ac.uk
The Disciplinary Committee of the RCVS has approved an application for restoration to the Register from an Oxfordshire veterinary surgeon who had been struck off for false certification.
In November 2007, the Committee decided that Mr John Williams, of the Avonvale Veterinary Practice in Ratley, near Banbury, should have his name removed from the RCVS Register, having found him guilty of disgraceful professional conduct. Mr Williams had admitted signing export health certificates for three horses in October 2006 to state that they had received negative test results for the contagious equine metritis organism, before these results were actually available.
At the time, Mr Williams was working in his capacity as an Official Veterinarian (OV) for DEFRA and he had previously been suspended from his official duties on three separate occasions, on the basis of export certification irregularities. It was accepted that Mr Williams had not been dishonest, but his approach to certification was described by the Disciplinary Committee as "either irresponsible or cavalier or both".
In December 2007, Mr Williams appealed against this decision to the Privy Council but this was dismissed at a Hearing the following June. He was then removed from the Register in July 2008.
When the Committee met on Monday to consider Mr Williams' application, they heard oral and written supporting evidence from veterinary surgeons and equine clients, and oral evidence from Mr Williams himself. The Committee was satisfied that Mr Williams accepted its previous findings and fully understood their seriousness. He described his removal from the Register as a "salutary experience" which had been highly significant for him and his family, both financially and emotionally.
The Committee stated: "Although the decision of the Committee to remove [Mr Williams] from the Register sent a clear message to the profession of the importance of certification, it should be emphasised that his removal was the consequence of his actions in signing certificates which he could not verify. This followed three previous occasions on which he had similarly signed certificates when he should not have done so."
However, the Committee was satisfied that Mr Williams would not in future sign certificates when he should not do so, even under severe client pressure. It was impressed with the continuing professional development he had undertaken whilst off the Register and noted that no questions had been raised over his conduct during this time.
It concluded that Mr Williams fully understood the importance of accurate certification and that restoring his name to the Register therefore posed no risk to animal welfare. Neither the public nor the profession would benefit from Mr Williams staying off the Register for a further period.
Alison Bruce, Disciplinary Committee Chairman, said: "We would like to make it clear that we always find it distressing to remove clinically competent veterinary surgeons from the Register because of an irresponsible and cavalier attitude towards certification. This would not be necessary if veterinary surgeons were to follow the Twelve Principles of Certification annexed to the RCVS Guide to Professional Conduct."
The Committee then approved Mr Williams' application and directed that his name should be restored to the Register.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
References
Launched in 2023 to address the growing need for skilled farm vets, the VetPartners Farm Academy was created to provide more opportunities for future vets to gain hands-on experience.
VetPartners Farm Director Ian Cure said: “By opening up on-farm and simulated farm experiences to students, the academy aims to bridge the gap between veterinary education and practical farm work – ensuring a strong pipeline of talent into the industry.
“Designed by farm vets, for vets of the future, our three-day academy complements university education by providing veterinary students with a structured on-farm experience that builds confidence and prepares them for a career in farm practice.
“By welcoming students into the Farm Academy, we’re helping them develop the practical skills, confidence and knowledge needed to thrive in farm animal practice from day one.
"The academy also offers those students who haven’t had previous farm exposure the chance to try farm vetting for the first time.
“With the agricultural sector facing increasing pressures, from sustainability targets to animal health challenges, ensuring the next generation of farm vets is well-prepared is more important than ever.”
This year’s academy will take place at a VetPartners practice in Cornwall, from 14th to 16th June.
Students will receive training from experienced farm vets, and gain valuable skills in herd health, disease management, and sustainable livestock production.
The Farm Academy programme in 2025 will offer students:
To apply, send a CV and covering letter to farmsupport@vetpartners.co.uk
Applications close 25th April.
Merial has announced the launch of V LINE, a new range of parasiticides sold exclusively through veterinary practices.
The first two products, called Broadline for cats and NexGard for dogs, will be unveiled at the BSAVA Congress at the start of next month.
Broadline is a broad-acting POM spot-on for cats containing eprinomectin, praziquantel, s-methoprene and fipronil, indicated for use against tapeworms, ticks, roundworms and fleas.
NexGard is a POM flea and tick control product for dogs given monthly as a palatable soft chew. It contains a novel active ingredient called afoxolaner which, according to Merial, has a new and distinct mode of action that provides a fast speed of flea kill.
Roddy Webster, Head of Pets at Merial said: "We are pleased to announce the launch of Broadline and NexGard. Merial is a market leader with a strong heritage in anti-parasitics and we have leveraged that expertise as well as our understanding of what pet owners want, to deliver these truly consumer-focused solutions. Such prescription-only innovations also demonstrate our ongoing commitment to the veterinary profession."